References
- VassalloCBrazzelliBArdigoMBorroniGThe irreplaceable image: nail changes in onco-hematologic patientsHaematologica20018633433611255290
- MinisiniAMTostiASobreroAFTaxane-induced nail changes: incidence, clinical presentation and outcomeAnn Oncol20031433333712562663
- RobertCSibaudVMateusCNail toxicities induced by systemic chemotherapy treatmentsLancet Oncol2015164e181e19025846098
- RosenACCaseECDuszaSWImpact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinicAm J Clin Dermatol20131432733323625802
- Cancer Therapy Evaluation ProgramCommon Terminology Criteria for Adverse Events, Version 4.0 Available from: http://ctep.cancer.govAccessed July 30, 2015
- CapriottiKCapriottiJALessinSThe risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysisBr J Dermatol Epub2212015
- GardenBCWuSLacoutureMEThe risk of nail changes with epidermal growth factor receptor inhibitorsJ Am Acad Dermatol201267340040822088429
- ParacciniBMIorizzoMStaraceMTostiADrug-induced nail diseasesDermatol Clin20062438739116798438
- CapriottiKCapriottiJATopical iodophor preparations: chemistry, microbiology, and clinical utilityDermatol Online J20121811123217942
- CapriottiKCapriottiJADimethyl sulfoxide: history, chemistry, and clinical utility in dermatologyJ Clin Aesthet Dermatol210259242623050031